The AI Drug That Reverses Aging

Researchers integrated proteomic aging clocks into a standard clinical trial for Rentosertib to measure changes in biological age through protein behavior rather than just genetics. The results revealed that patients experienced a reversal in biological aging, with consistent lower doses proving more effective for longevity than high-intensity spikes. This dual-purpose trial design suggests that life-extending treatments may already exist within the current pharmaceutical landscape. By leveraging systemic data, scientists can now uncover hidden health benefits in existing drugs without waiting decades for specialized longevity research. Note: This podcast was AI-generated, and sometimes AI can make mistakes. Please double-check any critical information. Sponsored by Embersilk LLC